Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-dependent hyper-viscoelastic parameter identification of human articular cartilage and substitute materials.

Journal of the mechanical behavior of biomedical materials·2022
Same author

[Acute-onset myopia].

Die Ophthalmologie·2022
Same author

Hyperelastic parameter identification of human articular cartilage and substitute materials.

Journal of the mechanical behavior of biomedical materials·2022
Same author

Establishment of a resazurin-based aortic valve tissue viability assay for dynamic culture in a microphysiological system.

Clinical hemorheology and microcirculation·2021
Same author

Complex mechanical behavior of human articular cartilage and hydrogels for cartilage repair.

Acta biomaterialia·2020
Same author

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions.

Clinical research in cardiology : official journal of the German Cardiac Society·2020

Related Experiment Video

Updated: May 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Lipid therapy in daily routine].

F Sonntag1, J R Schaefer, A K Gitt

  • 1Facharztpraxis für Innere Medizin, Henstedt-Ulzburg.

Deutsche Medizinische Wochenschrift (1946)
|October 2, 2012
PubMed
Summary
This summary is machine-generated.

Managing cardiovascular risk factors like dyslipidemia in primary care is challenging. Adding ezetimibe to statin therapy significantly improves LDL cholesterol target attainment for high-risk patients.

Related Experiment Videos

Last Updated: May 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

  • Cardiology
  • General Practice
  • Pharmacotherapy

Context:

  • High cardiovascular risk patients are common in general practice.
  • Guidelines recommend comprehensive management of modifiable risk factors, especially dyslipidemia.
  • A gap exists between clinical recommendations and real-world practice.

Purpose:

  • To assess the management of cardiovascular risk factors in high-risk patients in German general practice.
  • To evaluate the effectiveness of simvastatin monotherapy and combination therapy with ezetimibe.
  • To analyze target value attainment for LDL cholesterol, blood pressure, and HbA1c.

Summary:

  • The LIMA registry prospectively followed 13,924 high-risk patients (CAD, diabetes, PAD) treated with simvastatin 40mg.
  • After one year, 50% achieved LDL cholesterol targets, 65.8% reached blood pressure goals (<140/90 mmHg), and 40% of diabetics achieved HbA1c <6.5%.
  • Adding ezetimibe to simvastatin improved LDL cholesterol normalization, though clinical events remained significant.

Impact:

  • Comprehensive risk factor management in high-risk patients remains a clinical challenge.
  • Combination therapy with ezetimibe enhances the achievement of LDL cholesterol targets.
  • Findings highlight the need for optimized treatment strategies in primary care for cardiovascular disease prevention.